- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
FANCD2 Monoclonal Antibody GCE-6 / Fanconi Anemia Group D2 Antibody targets FANCD2, a central component of the Fanconi anemia DNA repair pathway responsible for maintaining genome stability. FANCD2 participates in the cellular response to DNA interstrand cross-links, lesions that prevent separation of the two DNA strands and interfere with replication and transcription. The protein functions in coordination with FANCI and a larger network of Fanconi anemia proteins that recognize replication-associated DNA damage and initiate repair. Defects in this pathway can cause chromosomal instability, impaired hematopoiesis, and increased susceptibility to malignancy.
FANCD2 forms a heterodimeric complex with FANCI, commonly called the ID complex. Following DNA damage or replication stress, the Fanconi anemia core complex promotes monoubiquitination of FANCD2 and FANCI. This modification stabilizes their association with damaged chromatin and supports recruitment of additional DNA repair factors. Monoubiquitinated FANCD2 accumulates in nuclear foci at sites of DNA damage, where it coordinates downstream repair events. The USP1-UAF1 deubiquitinating complex subsequently removes ubiquitin, helping regulate pathway activity and restore the proteins to their unmodified states.
The Fanconi anemia pathway operates in conjunction with nucleotide excision repair, translesion DNA synthesis, and homologous recombination. FANCD2 contributes to the processing of interstrand cross-links and helps coordinate repair intermediates generated during replication. Its interactions with proteins including BRCA1, BRCA2, and RAD51 connect Fanconi anemia signaling with homologous recombination and replication fork protection. FANCD2 also participates in responses to stalled replication forks and contributes to chromosome stability during cell division. These functions are essential for preventing the accumulation of DNA lesions and maintaining cellular viability under genotoxic stress.
Biallelic pathogenic variants in FANCD2 cause Fanconi anemia complementation group D2, a disorder associated with bone marrow failure, developmental abnormalities, and cancer predisposition. FANCD2 dysfunction has also been investigated in sporadic malignancies and responses to DNA-damaging therapies. Altered pathway activity can influence cellular sensitivity to cross-linking agents and other treatments that challenge DNA repair capacity. FANCD2 Monoclonal Antibody GCE-6 supports research into FANCD2 expression, Fanconi anemia pathway regulation, replication-associated DNA damage, and the molecular mechanisms connecting defective DNA repair with genomic instability and cancer.
For additional studies of FANCD2 expression and DNA repair pathway regulation, our FANCD2 Antibody provides complementary knockout-validated Western blot data.
Optimal dilution of the FANCD2 Monoclonal Antibody GCE-6 / Fanconi Anemia Group D2 Antibody should be determined by the researcher.
A synthesized peptide derived from human Fanconi Anemia Group D2 protein was used as the immunogen for the FANCD2 Monoclonal Antibody GCE-6.
The FANCD2 Monoclonal Antibody GCE-6 can be stored at -20oC.
Fanconi anemia protein D2 antibody, Fanconi anemia complementation group D2 antibody, Fanconi anemia group D2 protein antibody, Fanconi anemia D2 protein antibody, FA-D2 antibody, FAD2 antibody, FANCD2 DNA repair protein antibody, Fanconi anemia pathway protein D2 antibody, FANCD2 tumor suppressor pathway antibody, FANCD2 interstrand cross-link repair protein antibody, FANCD2 DNA damage response protein antibody, FANCD2 ubiquitination pathway antibody, FANCD2 nuclear repair protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.